Irene
Gañan Gomez
Investigadora
Universidad de Alcalá
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Alcalá (9)
2015
-
Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4
Annals of Hematology, Vol. 94, Núm. 3, pp. 379-392
2014
-
Changes in mitochondrial function induced by dequalinium precede oxidative stress and apoptosis in the human prostate-cancer cell line PC-3
Molecular Biology, Vol. 48, Núm. 3, pp. 359-370
-
Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest
PLoS ONE, Vol. 9, Núm. 4
2013
-
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells
Leukemia, Vol. 27, Núm. 11, pp. 2177-2186
-
Oncogenic functions of the transcription factor Nrf2
Free Radical Biology and Medicine, Vol. 65, pp. 750-764
-
Toll-like receptor alterations in myelodysplastic syndrome
Leukemia, Vol. 27, Núm. 9, pp. 1832-1840
2012
-
Raf/MEK/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562
Experimental Biology and Medicine, Vol. 237, Núm. 8, pp. 933-942
2011
-
Cytotoxic effects induced by combination of heliantriol B2 and dequalinium against human leukemic cell lines
Phytotherapy Research, Vol. 25, Núm. 4, pp. 603-610
-
Histone methylation in myelodysplastic syndromes
Epigenomics, Vol. 3, Núm. 2, pp. 193-205